We possess the expertise and resources to oversee the initiation of new studies in full compliance with EU REACH and REACH-like requirements. Our assistance extends to situations where authorities have identified deficiencies or inaccuracies in submitted dossiers.
Especially in the case of substances presenting significant hazard potential, specific studies are necessary to validate or refute presumed substance characteristics. Authoritative conclusive decisions in such cases have far-reaching implications for all registrants who have registered the respective substance within the volume band that necessitates an additional study according to their regulation requirements.